FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002304475> ?p ?o ?g. }

• W2002304475 endingPage "17" @default.
• W2002304475 startingPage "11" @default.
• W2002304475 abstract "To prospectively evaluate toxicity, biochemical failure-free survival (bFFS) and biopsy-proven local control for prostate cancer patients treated with 75.6 Gy in 42 fractions using 6-field conformal radiotherapy to prostate alone.From 1997 to 1999, 140 patients with T1-2NxM0, Gleason score<or=8, and PSA<or=20 ng/ml prostate cancer were assessed using Radiation Therapy Oncology Group acute and late toxicity scores. bFFS was determined for 120 patients treated without hormones. Post-treatment prostate biopsies were performed at a median of 3 years and a late toxicity questionnaire was administered at a median of 5 years.Clinically important acute toxicities were gastrointestinal (GI) grade 2: 22% and 3: 0%, and genitourinary (GU) grade 2: 24% and 3: 2%. Late physician-assessed toxicities were GI>or=grade 2: 2%, and GU>or=grade 2: 1%. The 3-year bFFS of patients failure-free before biopsy was 93% (95% CI: 83-100) from a negative biopsy and 22% (95% CI: 0-56) from a positive biopsy (P=0.001). Patients reported significantly more late toxicity than physicians (GI: P=0.003, GU: P<0.001). At 5.0 years median follow-up, cause-specific survival was 98% (95% CI: 96-100), overall survival was 91% (95% CI: 86-97), and bFFS was 55% (95% CI: 45-64).75.6 Gy caused modest levels of acute and late toxicity. Three-year biopsies predicted subsequent biochemical outcome." @default.
• W2002304475 created "2016-06-24" @default.
• W2002304475 creator A5000970066 @default.
• W2002304475 creator A5002629653 @default.
• W2002304475 creator A5018446991 @default.
• W2002304475 creator A5020744487 @default.
• W2002304475 creator A5021967618 @default.
• W2002304475 creator A5027354813 @default.
• W2002304475 creator A5028169952 @default.
• W2002304475 creator A5037763217 @default.
• W2002304475 creator A5042842956 @default.
• W2002304475 creator A5061721154 @default.
• W2002304475 creator A5062816009 @default.
• W2002304475 creator A5064900626 @default.
• W2002304475 creator A5078348186 @default.
• W2002304475 creator A5090458338 @default.
• W2002304475 creator A5091737661 @default.
• W2002304475 date "2005-07-01" @default.
• W2002304475 modified "2023-10-16" @default.
• W2002304475 title "A phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapy" @default.
• W2002304475 cites W1978906140 @default.
• W2002304475 cites W1996550652 @default.
• W2002304475 cites W1998100071 @default.
• W2002304475 cites W2007473361 @default.
• W2002304475 cites W2025027678 @default.
• W2002304475 cites W2025092866 @default.
• W2002304475 cites W2030105102 @default.
• W2002304475 cites W2043945205 @default.
• W2002304475 cites W2049670016 @default.
• W2002304475 cites W2056643793 @default.
• W2002304475 cites W2063960686 @default.
• W2002304475 cites W2071957168 @default.
• W2002304475 cites W2091780056 @default.
• W2002304475 cites W2103290459 @default.
• W2002304475 cites W2103429819 @default.
• W2002304475 cites W2106150382 @default.
• W2002304475 cites W2108773718 @default.
• W2002304475 cites W2134766389 @default.
• W2002304475 cites W2144406289 @default.
• W2002304475 cites W2146780512 @default.
• W2002304475 cites W2153674426 @default.
• W2002304475 cites W2157797729 @default.
• W2002304475 cites W2158190369 @default.
• W2002304475 cites W2163217542 @default.
• W2002304475 cites W4240713559 @default.
• W2002304475 doi "https://doi.org/10.1016/j.radonc.2005.06.002" @default.
• W2002304475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15990187" @default.
• W2002304475 hasPublicationYear "2005" @default.
• W2002304475 type Work @default.
• W2002304475 sameAs 2002304475 @default.
• W2002304475 citedByCount "43" @default.
• W2002304475 countsByYear W20023044752012 @default.
• W2002304475 countsByYear W20023044752013 @default.
• W2002304475 countsByYear W20023044752015 @default.
• W2002304475 countsByYear W20023044752017 @default.
• W2002304475 countsByYear W20023044752019 @default.
• W2002304475 countsByYear W20023044752020 @default.
• W2002304475 countsByYear W20023044752021 @default.
• W2002304475 countsByYear W20023044752022 @default.
• W2002304475 crossrefType "journal-article" @default.
• W2002304475 hasAuthorship W2002304475A5000970066 @default.
• W2002304475 hasAuthorship W2002304475A5002629653 @default.
• W2002304475 hasAuthorship W2002304475A5018446991 @default.
• W2002304475 hasAuthorship W2002304475A5020744487 @default.
• W2002304475 hasAuthorship W2002304475A5021967618 @default.
• W2002304475 hasAuthorship W2002304475A5027354813 @default.
• W2002304475 hasAuthorship W2002304475A5028169952 @default.
• W2002304475 hasAuthorship W2002304475A5037763217 @default.
• W2002304475 hasAuthorship W2002304475A5042842956 @default.
• W2002304475 hasAuthorship W2002304475A5061721154 @default.
• W2002304475 hasAuthorship W2002304475A5062816009 @default.
• W2002304475 hasAuthorship W2002304475A5064900626 @default.
• W2002304475 hasAuthorship W2002304475A5078348186 @default.
• W2002304475 hasAuthorship W2002304475A5090458338 @default.
• W2002304475 hasAuthorship W2002304475A5091737661 @default.
• W2002304475 hasConcept C121608353 @default.
• W2002304475 hasConcept C126322002 @default.
• W2002304475 hasConcept C126894567 @default.
• W2002304475 hasConcept C133507102 @default.
• W2002304475 hasConcept C141071460 @default.
• W2002304475 hasConcept C143998085 @default.
• W2002304475 hasConcept C2775934546 @default.
• W2002304475 hasConcept C2776235491 @default.
• W2002304475 hasConcept C2780192828 @default.
• W2002304475 hasConcept C29456083 @default.
• W2002304475 hasConcept C29730261 @default.
• W2002304475 hasConcept C509974204 @default.
• W2002304475 hasConcept C71924100 @default.
• W2002304475 hasConcept C90924648 @default.
• W2002304475 hasConceptScore W2002304475C121608353 @default.
• W2002304475 hasConceptScore W2002304475C126322002 @default.
• W2002304475 hasConceptScore W2002304475C126894567 @default.
• W2002304475 hasConceptScore W2002304475C133507102 @default.
• W2002304475 hasConceptScore W2002304475C141071460 @default.
• W2002304475 hasConceptScore W2002304475C143998085 @default.
• W2002304475 hasConceptScore W2002304475C2775934546 @default.
• W2002304475 hasConceptScore W2002304475C2776235491 @default.
• W2002304475 hasConceptScore W2002304475C2780192828 @default.

• next